United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 765,205 | 254,359 | 426,509 | 397,697 | 497,291 |
| Marketable Securities | 156,630 | 185,774 | 230,356 | 297,842 | 270,372 |
| Receivables | 179,642 | 169,214 | 156,153 | 162,287 | 139,903 |
| Inventories | 80,844 | 77,249 | 72,465 | 66,927 | 63,669 |
| Other current assets | 46,202 | 142,443 | 108,608 | 32,836 | 107,250 |
| TOTAL | $1,228,523 | $829,039 | $994,091 | $957,589 | $1,078,485 |
| Non-Current Assets | |||||
| PPE Net | 474,770 | 471,862 | 474,680 | 478,421 | 481,049 |
| Investments And Advances | 91,706 | 121,467 | 116,493 | 122,658 | 205,953 |
| Intangibles | 0 | 0 | 0 | 29,465 | 0 |
| Other Non-Current Assets | 364,234 | 314,454 | 309,350 | 296,277 | 306,563 |
| TOTAL | $930,710 | $907,783 | $900,523 | $926,821 | $993,565 |
| Total Assets | $2,159,233 | $1,736,822 | $1,894,614 | $1,884,410 | $2,072,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 30,017 | 32,282 | 115,222 | 126,414 | 291,315 |
| Accounts payable and accrued liabilities | 113,346 | 110,110 | 90,130 | 85,382 | 127,961 |
| Other current liabilities | 413,979 | 400,022 | 441,396 | 292,514 | 341,372 |
| TOTAL | $557,342 | $542,414 | $646,748 | $504,310 | $760,648 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 135,021 | 153,935 | 156,243 | 137,744 | 131,023 |
| TOTAL | $135,021 | $153,935 | $156,243 | $137,744 | $131,023 |
| Total Liabilities | $692,363 | $696,349 | $802,991 | $642,054 | $891,671 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,629 | 45,540 | 46,261 | 46,666 | 47,509 |
| Common Shares | 685 | 682 | 665 | 660 | 642 |
| Retained earnings | 1,615,109 | 1,150,684 | 1,051,473 | 1,068,114 | 952,179 |
| Other shareholders' equity | -21,812 | -19,866 | -21,513 | -16,559 | -16,525 |
| TOTAL | $1,466,870 | $1,040,473 | $1,091,623 | $1,242,356 | $1,180,379 |
| Total Liabilities And Equity | $2,159,233 | $1,736,822 | $1,894,614 | $1,884,410 | $2,072,050 |